ISRG Intuitive Surgical
FY2025 10-K
Intuitive Surgical (ISRG) filed its fiscal year 2025 10-K annual report with the SEC on Feb 3, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business: robotic-assisted minimally invasive surgical systems with integrated instruments, accessories, learning, and digital solutions
- • New product emphasis: launched da Vinci 5 system with force feedback, 10,000x computing power of Xi, and My Intuitive+ digital subscription package
Management Discussion & Analysis
- • Tariffs increased cost of revenues by $63.0M in 2025; ongoing tariff impact expected to rise in 2026
- • Installed base: 1,231 da Vinci 5 systems, 377 da Vinci SP systems as of Dec 31, 2025
Risk Factors
- • UK medical device regulatory changes, new post-market rules effective June 16, 2025, with additional rules expected in 2026 potentially delaying UK market approval
- • China anti-corruption campaign in healthcare since July 2023 causing tender cancellations, reducing system placements in 2025 versus expectations
Financial SummaryXBRL
Revenue
$10.1B
Net Income
$2.9B
Gross Margin
66.0%
Operating Margin
29.3%
Net Margin
28.4%
ROE
16.0%
Total Assets
$20.5B
EPS (Diluted)
$7.87
Operating Cash Flow
$3.0B
Source: XBRL data from Intuitive Surgical FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Intuitive Surgical
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.